Skip to main content

Closed

XLO: Xilio Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

42thpctl

Volume

0.22×avg

Market Cap

59.90MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Xilio Therapeutics, Inc.

XLONASDAQ Global Select·USD·Closed

Xilio Therapeutics, Inc.

XLONASDAQ·USD·Closed

$9.11

+0.29%

$9.11

+$0.03 (0.29%)

52W Range

42thpctl

Volume

0.22×avg

Mkt Cap

59.90MUSD

P/E

-1.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings